-
-
Login
Summer 2026 has brought important developments across FreeStyle Libre, from Libre 3 Plus and rapid growth in hybrid closed-loop use to new ADA evidence supporting Libre Duo, AI-powered Libre Assist and Abbott's wider move into connected health.
A research smart ring can monitor glucose and ketones from sweat continuously. It's an exciting step, but it remains a long way from replacing CGMs.
EOFlow has secured a significant legal victory after a US appeals court overturned a $59.4 million judgment awarded to Insulet in the long-running dispute between the two patch pump manufacturers.
CamDiab’s automated insulin delivery technology gets regulatory progress toward fully closed-loop system.
News from Portal Diabetes that new medtech for an implantable insulin pump has reached an early regulatory milestone in the US.
FDA Commissioner Martin Makary recently highlighted the role of CGMs in preventing chronic conditions, questioning why they are only available on prescription. Could there be any benefit to the diabetes community of a policy change?
New medtech startup, Luna Health, based in the US, have raised $23.6 million to advance a patch pump designed specifically for overnight use only.
FDA approval of Simplera Sync sensor paired with MiniMed™ 780G insulin pump.
Latest news from key diabetes conference covering the latest in medtech, treatments, research and 'cures'.
Dexcom's financial filings reveal a warning letter from the FDA regarding processing in 2 of its manufacturing plants.
A new CGM launches this February in the UK.
News that Abbott and Dexcom have agreed not to sue each other for patents relating to their CGM tech for another 10 years.
